Skip to content
← Full study record

NCT00592319 · MORE INFO

Limitations, agreements, and source contact

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma · Source last updated 2012-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
We failed to recruit a total of 30 cases, due to (1) This disease is relative less common in clinic; and (2) particularly, more and more of patients now had a serious concern in safety of Celebrex due to news and warnings to public in recent years.
point Of Contact
email
zwang@bu.edu
organization
Trustee of Boston Univ. Medical Campus
phone
617-414-1590
title
Dr. Zhi Wang
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
We failed to recruit a total of 30 cases, due to (1) This disease is relative less common in clinic; and (2) particularly, more and more of patients now had a serious concern in safety of Celebrex due to news and warnings to public in recent years.
point Of Contact
email
zwang@bu.edu
organization
Trustee of Boston Univ. Medical Campus
phone
617-414-1590
title
Dr. Zhi Wang

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice